HKU Scholars Hub: Browsing DSpace

Browsing by Author Buti, M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 18 of 18

	Title	Author(s)	Issue Date	Views
	Assay for Hepatitis B Core-related Antigen Identify Patients With High Viral Load: Systematic Review and Meta-analysis of Individual Participant Data Journal:Clinical Gastroenterology and Hepatology	Yoshida, K Desbiolles, A Feldman, SF Ahn, SH Alidjinou, EK Atsukawa, M Bocket, L Brunetto, MR Buti, M Carey, I Caviglia, GP Chen, EQ Cornberg, M Enomoto, M Honda, M Zu Siederdissen, CH Ishigami, M Janssen, HLA Maasoumy, B Matsui, T Matsumoto, A Nishiguchi, S Riveiro-Barciela, M Takaki, A Tangkijvanich, P Toyoda, H van Campenhout, MJH Wang, B We, L Yang, HI Yano, Y Yatsuhashi, H Yuen, MF Tanaka, E Lemoine, M Tanaka, Y Shimakawa, Y	2020	26
	Bone and renal safety are improved in chronic hbv patients 1 year after switching to tenofovir alafenamide (TAF) from tenofovir disoproxil fumarate (TDF) Proceeding/Conference:Gut	Chan, HLY Seto, WKW Buti, M Izumi, N Lim, YS Kao, J Streinu-Cercel, A Nurmukhametova, E Ma, X Tabak, F Jablkowski, M Suri, V Flaherty, J Lau, A Gaggar, A Mo, S Chowdhury, A Fung, S Chuang, W Gane, E	2019	34
	Bone and Renal Safety Are Improved in Chronic HBV Patients 1 Year after Switching to Tenofovir Alafenamide (TAF) from Tenofovir Disoproxil Fumarate (TDF) Proceeding/Conference:Hepatology	Seto, WKW Buti, M Izumi, N Lim, YS Kao, JH Streinu-Cercel, A Nurmukhametova, E Ma, X Tabak, F Jablkowski, M Suri, V Flaherty, JF Lau, AH Gaggar, A Mo, S Chowdhury, A Fung, SK Chuang, WL Gane, EJ	2018	73
	Entecavir versus tenofovir disoproxil fumarate for seroclearance of hepatitis B surface antigen in an international real-world cohort Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology	Hsu, Y-C Jun, DW Peng, C-Y Yeh, ML Trinh, HY Wong, GLH Kim, SE Chen, GH Oh, HW Lin, C-H Yoon, E Ahn, SB Hung, D Cho, YK Jeong, JY Jeong, SW Kim, HS Xie, Q Liu, L Barciela, MR Tsai, P-C Vargas-Accarino, E Toyoda, H Enomoto, M Preda, C Marciano, S Hoang, J Huang, C-F Kozuka, R Yasuda, S Istratescu, D Lee, DH Su, J-Y Huang, Y-T Huang, J-F Dai, C-Y Chuang, W-L Yuen, RMF Gadano, AC Cheung, RC Lim, SG Buti, M Wong, VWS Yu, M-L Nguyen, MH	2021
	HBsAg loss after nucleo(s)tide analogue withdrawal: relationship with viral antigen levels and hbv genotype Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology	Sonneveld, MJ Chiu, S-M Park, JY Kaewdech, A Seto, WKW Tanaka, Y Carey, I Papatheodoridi, M Van Bömmel, F Brakenhoff, S Berg, T Zoulim, F Ahn, SH Dalekos, GN Erler, NS Zu Siederdissen, CN Wedemeyer, H Cornberg, M Yuen, RMF Agarwal, K Boonstra, A Buti, M Piratvisuth, T Papatheodoridis, G Chen, CH Maasoumy, B CREATE study group,	2021
	IMC-I109V, a novel T cell receptor (TCR) bispecific (ENVxCD3) designed to eliminate HBV-infected hepatocytes in chronic HBV patients: initial data from a first-in-human study. Poster Presentation (SAT437) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Bourgeois, S Lim, Y-S Gane, EJ Lee, HW Cheng, W Heo, J Kim, W Buti, M Thompson, A Matthews, G Janczewska, E Ryder, S Andrade, RJ Yuan, Y Benlahrech, A Wustner, J Dorrell, L Yuen, RMF	2022
	IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) Proceeding/Conference:Hepatology	Lim, Y Chan, HLY Seto, WKW Ning, Q Agarwal, K Janssen, HL Pan, CQ Chuang, WL Izumi, N Fung, SK Shalimar,Brunetto, MR Flaherty, JF Mo, S Cheng, C Lin, L Gaggar, A Subramanian, M Marcellin, P Gane, EJ Hou, J Buti, M	2019	119
	Incidences and Determinants of Functional Cure during Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Journal:The Journal of Infectious Diseases	Hsu, YC Yeh, ML Wong, GLH Chen, CH Peng, CY Buti, M Enomoto, M Xie, Q Trinh, H Preda, C Liu, L Cheung, KS Yeo, YH Hoang, J Huang, CF Riveiro-Barciela, M Kozuka, R Istratescu, D Tsai, PC Accarino, EV Lee, DH Wu, JL Huang, JF Dai, CY Cheung, R Chuang, WL Yuen, MF Wong, VWS Yu, ML Nguyen, MH	2021
	Low HBcrAg and HBsAg levels identify patients most likely to achieve sustained response after nucleos(t)ide analogue cessation: results from a global individual patient data meta-analysis (create study) Proceeding/Conference:Journal of Hepatology	Sonneveld, M Park, JY Seto, WKW Tanaka, Y Carey, I Papatheodoridi, M Zoulim, F Ahn, SH Dalekos, G Hoener zu Siederdissen, C Cornberg, M Yuen, RMF Agarwal, K Boonstra, A Buti, M Papatheodoridis, G Maasoumy, B	2020	31
	Prediction Of Sustained Response After Nucleo(s)tide Analogue Cessation Using Hbsag And Hbcrag Levels – A Multicenter Study (create) Journal:Clinical Gastroenterology and Hepatology	Sonneveld, MJ Park, JY Kaewdech, A Seto, WK Tanaka, Y Carey, I Papatheodoridi, M van Bommel, F Berg, T Zoulim, F Ahn, SH Dalekos, GN Erler, NS Honer zu Siederdissen, C Wedemeyer, H Cornberg, M Yuen, MF Agarwal, K Boonstra, A Buti, M Piratvisuth, T Papatheodoridis, G Maasoumy, B	2020
	Predictors of HBsAg loss after cessation of nucleo (s)tide analogue therapy in asian patients with low HBsAg levels. Poster Presentation (SAT344) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Sonneveld1, M Chiu, SM Park, JY Kaewdech, A Seto, WKW Tanaka, Y Carey, I Papatheodoridi, M van Bömmel, F Brakenhoff, S Berg, T Zoulim, F Ahn, SH Dalekos, G Erler, N Hoener zu Siederdissen, C Wedemeyer1, H Cornberg, M Yuen, RMF Agarwa, K Boonstra, A Buti, M Piratvisuth, T Papatheodoridis8, G Chen, C-H Maasoumy, B	2022
	Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels Journal:Journal of Hepatology	Sonneveld, MJ Chiu, SM Park, JY Brakenhoff, SM Kaewdech, A Seto, WKW Tanaka, Y Carey, I Papatheodoridi, M van Bommel, F Berg, T Zoulim, F Ahn, SH Dalekos, GS Erler, NS Honer zu Siederdissen, C Wedemeyer, H Cornberg, M Yuen, RMF Agarwal, K Boonstra, A Buti, M Piratvisuth, T Papatheodoridis, G Chen, CH Maasoumy, B	2022	6
	Real-world rates of hepatitis B surface antigen (HBsAg) seroclearance in patients with chronic hepatitis B (CHB): a systematic review, conventional aggregated data meta-analysis (ADMA) and individual patient data meta-analysis (IPDMA) Proceeding/Conference:Gastroenterology	Yeo, YH Ho, HJ Yang, HI Tseng, TC Kwak, M-S Park, YM Fung, JYY Buti, M Rodriguez, M Treeprsertsuk, S Preda, CM Ungtrakul, T Charatcharoenwithaya, P Li, X Le, MH Wei, B Zou, B Le, AK Jeong, D Chien, N Kam, L Hosaka, T Riveiro, M Proca, D Suzuki, F Kobayashi, M Sriprayoon, T Chong, Y Tanwandee, T Yuen, RMF Lee, H-S Kao, J-H Lok, A Wu, C-Y Nguyen, MH	2018	2
	Sa1483 - Real-World Rates of Hepatitis B Surface Antigen (HBSAG) Seroclearance in Patients with Chronic Hepatitis B (CHB): A Systematic Review, Conventional Aggregated Data Meta-Analysis (ADMA) and Individual Patient Data Meta-Analysis (IPDMA) Proceeding/Conference:Gastroenterology	Yeo, YH Ho, HJ Yang, HI Tseng, TC Kwak, MS Park, YM Fung, JYY Buti, M Rodriguez, M Treeprasertsuk, S Preda, CM Ungtrakul, T Charatcharoenwitthaya, P Li, XY Le, MH Wei, B Zou, BY Le, AK Jeong, D Chien, N Kam, L Hosakh, T Rivetro, M Proca, D Suzuki, F Kobayashi, M Sriprayoon, T Chong, Y Tanwandee, T Yuen, RMF Lee, HS Kao, JH Lok, A Wu, CY Nguyen, MH	2018	3
	Telbivudine improves renal function in patients with chronic hepatitis B Journal:Gastroenterology	Gane, EJ Deray, G Liaw, YF Lim, SG Lai, CL Rasenack, J Wang, Y Papatheodoridis, G Di Bisceglie, A Buti, M Samuel, D Uddin, A Bosset, S Trylesinski, A	2014	31
	Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial Journal:The Lancet Gastroenterology & Hepatology	Buti, M Gane, E Seto, WKW Chan, HL Chuang, WL Stepanova, T Hui, AJ Lim, YS Mehta, R Janssen, H Acharya, SK Flaherty, J Massetto, B Cathcart, AL Kim, K Gaggar, A Subramanian, GM McHutchison, J Pan, C Brunetto, M Izumi, N Marcellin, P	2016	20
	Three Year Efficacy and Safety of Tenofovir Alafenamide (TAF) Compared to Tenofovir Disoproxil Fumarate (TDF) in Hbeag-Negative and Hbeag-Positive Patients with Chronic Hepatitis B Proceeding/Conference:Hepatology	Chan, HLY Lim, YS Seto, WKW Agarwal, K Brunetto, MR Janssen, HLA Caruntu, F Stepanova, T Tsang, O Yatsuhashi, H Tak, WY Chen, CY Celen, M Sun, V Flaherty, JF Lin, L Cathcart, A Gaggar, A Pan, CQ Shalimar Buti, M	2018	11
	Title: Real-world effectiveness and safety of interferon-free DAAS for 14,676 hepatitis C (CHC) patients with genotypes 1, 2, 3, 4 and 6: a multinational study Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology	Ji, F Ogawa, E Huang, C-F Toyoda, H Wong, YY Iio, E Jun, DW Liu, L Uojima, H Nozaki, A Chuma, M Tseng, C-H Hsu, .Y-C Atsukawa, M Haga, H Enomoto, M Tamori, A Trinh, HN Landis, C Lee, DH Watanabe, T Takahashi, H Abe, H Yokohama, K Asai, A Eguchi, Y Li, J Wang, XZ Li, J Liu, JP Jing, L Preda, CM Lam, C Huang, R Ye, Q Pan, HY Zhang, JJ Cai, DC Wang, Q Huang, D Wong, GLH Li, JY Kato, M Shimoda, S Furusyo, N Nakamuta, M Nomura, H Kajiwara, E Yoon, E Ahn, SB Azuma, K Dohmen, K Jung, JH Song, DS Kawano, A Koyanagi, T Ooho, A Satoh, T Takahashi, K Yeh, M-L Tsai, P-C Yasuda, S Dang, SG Li Sr., ZF Okubo, T Itokawa, N Fukunishi, S Jun, M Ishikawa, T Takaguchi, K Senoh, T Zhang, MY Zhao, CQ Tran, S Maeda, M Chuang, W-L Huang, JF Dai, C-Y Cheung, RC Buti, M Niu, JQ Xie, W Ren, H Lim, SG Wu, C Yuen, RMF Shang, J Zhu, Q Ueno, Y Tanaka, Y Hayashi, J Yu, M-L Nguyen, MH	2021

Showing results 1 to 18 of 18